vs
Core AI Holdings, Inc.（CHAI）与Ensysce Biosciences, Inc.（ENSC）财务数据对比。点击上方公司名可切换其他公司
Core AI Holdings, Inc.的季度营收约是Ensysce Biosciences, Inc.的2.0倍（$3.7M vs $1.9M），Core AI Holdings, Inc.净利率更高（-145.7% vs -147.0%，领先1.3%）
Inflection AI公司是一家美国科技企业，成立于2022年，总部位于加利福尼亚州帕洛阿尔托，属于公益公司类型。该公司主营机器学习与生成式人工智能相关的硬件及应用开发，在生成式AI领域开展业务布局。
Ensysce Biosciences是一家临床阶段生物技术公司，专注于开发疼痛管理和肿瘤适应症领域的创新前药疗法，其专有平台可降低阿片类药物滥用风险并提升治疗有效性，面向全球医疗医药市场，重点解决未被满足的临床需求。
CHAI vs ENSC — 直观对比
营收规模更大
CHAI
是对方的2.0倍
$1.9M
净利率更高
CHAI
高出1.3%
-147.0%
损益表 — Q3 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $3.7M | $1.9M |
| 净利润 | $-5.4M | $-2.8M |
| 毛利率 | 20.1% | — |
| 营业利润率 | -135.2% | -147.8% |
| 净利率 | -145.7% | -147.0% |
| 营收同比 | — | 44.4% |
| 净利润同比 | — | 22.3% |
| 每股收益（稀释后） | $-1.74 | $-0.51 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CHAIENSC
| Q4 25 | — | $1.9M | ||
| Q3 25 | $3.7M | $493.1K | ||
| Q2 25 | — | $1.4M | ||
| Q1 25 | — | $1.3M | ||
| Q4 24 | — | $1.3M | ||
| Q3 24 | — | $3.4M | ||
| Q4 23 | — | $515.0K | ||
| Q3 23 | $1.8M | $435.4K |
净利润CHAIENSC
| Q4 25 | — | $-2.8M | ||
| Q3 25 | $-5.4M | $-3.7M | ||
| Q2 25 | — | $-1.7M | ||
| Q1 25 | — | $-1.9M | ||
| Q4 24 | — | $-3.6M | ||
| Q3 24 | — | $661.8K | ||
| Q4 23 | — | $-3.5M | ||
| Q3 23 | $-1.9M | $-2.7M |
毛利率CHAIENSC
| Q4 25 | — | — | ||
| Q3 25 | 20.1% | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q4 23 | — | — | ||
| Q3 23 | 26.6% | — |
营业利润率CHAIENSC
| Q4 25 | — | -147.8% | ||
| Q3 25 | -135.2% | -758.7% | ||
| Q2 25 | — | -127.6% | ||
| Q1 25 | — | -149.1% | ||
| Q4 24 | — | -274.3% | ||
| Q3 24 | — | 18.9% | ||
| Q4 23 | — | -612.7% | ||
| Q3 23 | -120.8% | -621.8% |
净利率CHAIENSC
| Q4 25 | — | -147.0% | ||
| Q3 25 | -145.7% | -756.3% | ||
| Q2 25 | — | -126.4% | ||
| Q1 25 | — | -147.4% | ||
| Q4 24 | — | -273.4% | ||
| Q3 24 | — | 19.4% | ||
| Q4 23 | — | -680.4% | ||
| Q3 23 | -100.7% | -618.0% |
每股收益（稀释后）CHAIENSC
| Q4 25 | — | $-0.51 | ||
| Q3 25 | $-1.74 | $-1.29 | ||
| Q2 25 | — | $-0.79 | ||
| Q1 25 | — | $-1.39 | ||
| Q4 24 | — | $-0.89 | ||
| Q3 24 | — | $1.00 | ||
| Q4 23 | — | $-66.47 | ||
| Q3 23 | $-1.04 | $-0.87 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $3.5M | $4.3M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $15.4M | $3.2M |
| 总资产 | $20.2M | $7.5M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资CHAIENSC
| Q4 25 | — | $4.3M | ||
| Q3 25 | $3.5M | $1.7M | ||
| Q2 25 | — | $2.2M | ||
| Q1 25 | — | $3.1M | ||
| Q4 24 | — | $3.5M | ||
| Q3 24 | — | $4.2M | ||
| Q4 23 | — | $1.1M | ||
| Q3 23 | $366.2K | $1.5M |
股东权益CHAIENSC
| Q4 25 | — | $3.2M | ||
| Q3 25 | $15.4M | $1.2M | ||
| Q2 25 | — | $3.4M | ||
| Q1 25 | — | $3.0M | ||
| Q4 24 | — | $3.7M | ||
| Q3 24 | — | $6.9M | ||
| Q4 23 | — | $-322.9K | ||
| Q3 23 | $12.3M | $1.5M |
总资产CHAIENSC
| Q4 25 | — | $7.5M | ||
| Q3 25 | $20.2M | $3.2M | ||
| Q2 25 | — | $5.6M | ||
| Q1 25 | — | $4.6M | ||
| Q4 24 | — | $5.6M | ||
| Q3 24 | — | $9.4M | ||
| Q4 23 | — | $2.7M | ||
| Q3 23 | $16.2M | $3.2M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $-1.5M |
| 自由现金流经营现金流 - 资本支出 | — | — |
| 自由现金流率自由现金流/营收 | — | — |
| 资本支出强度资本支出/营收 | — | — |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流CHAIENSC
| Q4 25 | — | $-1.5M | ||
| Q3 25 | — | $-1.9M | ||
| Q2 25 | — | $-2.7M | ||
| Q1 25 | — | $-1.7M | ||
| Q4 24 | — | $-764.1K | ||
| Q3 24 | — | $-1.0M | ||
| Q4 23 | — | $-1.8M | ||
| Q3 23 | $-2.7M | $-2.3M |
现金转化率CHAIENSC
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | -1.54× | ||
| Q4 23 | — | — | ||
| Q3 23 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
